Cancer Immunology and Immunotherapy - Postgraduate Module

Program Overview

This postgraduate module in Cancer Immunology and Immunotherapy from the University of Birmingham focuses on the groundbreaking field of immunotherapy, exploring the immune system's potential to combat cancer. Through an essay and exam, students assess their knowledge and analyze the scientific basis and clinical applications of these transformative treatments.

Program Outline

• It explores the challenges faced by immunotherapy strategies and examines the advantages and disadvantages of various antigenic targets currently used in immunotherapy.
• It reviews a range of current immunotherapy approaches, focusing on their scientific basis and clinical mode of action.
These strategies include:
• Antibody therapies
• Checkpoint blockade strategies
• T cell /chimeric antigen receptor adoptive therapy
• Cancer vaccines
• Module Attendance:
• 20 credit module over 2 weeks.
• Module Dates:
• 21/11/2022 - 8/12/2022

Assessment:

• Assessment Components:
• Essay - 3000 words (50% of overall mark)
• Exam - 25 multiple choice questions plus 3/4 short answer questions (50% of overall mark)

Teaching:

• Module Leads:
• Professor Ben Willcox
• Dr Fiyaz Mohammed

Other:

• Program Type: Postgraduate, Module
• Program Name: Cancer Immunology and Immunotherapy
• Institution: Institute of Cancer and Genomic Sciences, University of Birmingham
• Program Focus: Transforming cancer treatment through immunotherapy approaches.
• Program Highlights:
• Emphasizes the remarkable effects of cancer immunotherapy in clinical trials, even in late-stage disease.
• Program Availability:
• The module was offered in November/December 2022.